Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer
Status:
Unknown status
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
Scirrhous gastric cancer, also known as linitis plastic or Borrmann type 4, is an aggressive
tumor with an extremely poor prognosis. Aggressive surgical procedures and adjuvant
chemotherapies have not improved the survival rate. The purpose of this study is to determine
whether neoadjuvant Chemotherapy with SEEOX regimen via intra-arterial and intravenous
administration are effective in the treatment of Borrmann type 4 gastric cancer.